Xinying Wang

Benefits of SGLT2 inhibitors in arrhythmias

Yunlong Xia, G. Zhan, Xiaolei Yang, 2022, Frontiers in Cardiovascular Medicine.

A Retrospective Study of the Relationship Between the Triglyceride Glucose Index and Myocardial Revascularization for New-Onset Acute Coronary Syndromes

Li-bing Lin, Yinong Jiang, Xiaolei Yang, 2022, Frontiers in Cardiovascular Medicine.

Different Involvement of OAT in Renal Disposition of Oral Anticoagulants Rivaroxaban, Dabigatran, and Apixaban.

H. Kusuhara, T. Nakanishi, I. Tamai, 2017, Journal of pharmaceutical sciences.

Arterial stiffness is associated with cancer mortality: Insight from Kailuan study

Shuohua Chen, Shouling Wu, Yunlong Xia, 2023, Cancer medicine.

Early atrial remodeling predicts the risk of cardiovascular events in patients with metabolic syndrome: a retrospective cohort study

Sharen Lee, Yunlong Xia, Xiaolei Yang, 2023, Frontiers in Cardiovascular Medicine.

Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced atrial fibrillation by regulating atrial electrical and structural remodeling.

Yuqi Tang, Jiatian Li, Xinying Wang, 2024, European journal of pharmacology.